Implementation and Evaluation of the SAEM Algorithm for Longitudinal Ordered Categorical Data with an Illustration in Pharmacokinetics–Pharmacodynamics
暂无分享,去创建一个
[1] Mats O Karlsson,et al. Population pharmacokinetics of clomethiazole and its effect on the natural course of sedation in acute stroke patients. , 2003, British journal of clinical pharmacology.
[2] Mats O. Karlsson,et al. Performance in population models for count data, part I: maximum likelihood approximations , 2009, Journal of Pharmacokinetics and Pharmacodynamics.
[3] G. Molenberghs,et al. Longitudinal data analysis , 2008 .
[4] R. Miller,et al. Exposure‐response Analysis for Spontaneously Reported Dizziness in Pregabalin‐treated Patient With Generalized Anxiety Disorder , 2008, Clinical pharmacology and therapeutics.
[5] Mats O. Karlsson,et al. Comparison of proportional and differential odds models for mixed-effects analysis of categorical data , 2008, Journal of Pharmacokinetics and Pharmacodynamics.
[6] R A O'REILLY,et al. STUDIES ON THE COUMARIN ANTICOAGULANT DRUGS: THE PHARMACODYNAMICS OF WARFARIN IN MAN. , 1963, The Journal of clinical investigation.
[7] Lewis B. Sheiner,et al. Simultaneous vs. Sequential Analysis for Population PK/PD Data I: Best-Case Performance , 2003, Journal of Pharmacokinetics and Pharmacodynamics.
[8] Marc Lavielle,et al. Performance in population models for count data, part II: A new SAEM algorithm , 2009, Journal of Pharmacokinetics and Pharmacodynamics.
[9] J Whitehead,et al. A random effects model for ordinal responses from a crossover trial. , 1991, Statistics in medicine.
[10] Lewis B. Sheiner,et al. Simultaneous vs. Sequential Analysis for Population PK/PD Data II: Robustness of Methods , 2003, Journal of Pharmacokinetics and Pharmacodynamics.
[11] Matts Kågedal,et al. Modelling a Spontaneously Reported Side Effect by Use of a Markov Mixed-Effects Model , 2005, Journal of Pharmacokinetics and Pharmacodynamics.
[12] Marc Lavielle,et al. Maximum likelihood estimation in nonlinear mixed effects models , 2005, Comput. Stat. Data Anal..
[13] P M Aggeler,et al. Studies on Coumarin Anticoagulant Drugs: Initiation of Warfarin Therapy Without a Loading Dose , 1968, Circulation.
[14] Robert J. Bauer,et al. A survey of population analysis methods and software for complex pharmacokinetic and pharmacodynamic models with examples , 2007, The AAPS Journal.
[15] M O Karlsson,et al. Diagnosing Model Diagnostics , 2007, Clinical pharmacology and therapeutics.
[16] R. Savic,et al. Importance of Shrinkage in Empirical Bayes Estimates for Diagnostics: Problems and Solutions , 2009, The AAPS Journal.
[17] D R Stanski,et al. Population pharmacodynamic model for ketorolac analgesia , 1996, Clinical pharmacology and therapeutics.
[18] L B Sheiner,et al. A new approach to the analysis of analgesic drug trials, illustrated with bromfenac data , 1994, Clinical pharmacology and therapeutics.
[19] Marc Lavielle,et al. Estimation of Population Pharmacokinetic Parameters of Saquinavir in HIV Patients with the MONOLIX Software , 2007, Journal of Pharmacokinetics and Pharmacodynamics.
[20] Siv Jönsson,et al. Estimating Bias in Population Parameters for Some Models for Repeated Measures Ordinal Data Using NONMEM and NLMIXED , 2004, Journal of Pharmacokinetics and Pharmacodynamics.
[21] France Mentré,et al. Fisher information matrix for nonlinear mixed effects multiple response models: Evaluation of the appropriateness of the first order linearization using a pharmacokinetic/pharmacodynamic model , 2009, Statistics in medicine.